Management of symptomatic bone metastases from breast cancer with concomitant use of external radiotherapy and ibandronate: results of a prospective, pilot study

Breast J. 2010 Jan-Feb;16(1):92-4. doi: 10.1111/j.1524-4741.2009.00867.x. Epub 2009 Nov 19.
No abstract available

Publication types

  • Letter

MeSH terms

  • Bone Density Conservation Agents / administration & dosage*
  • Bone Neoplasms / mortality
  • Bone Neoplasms / secondary*
  • Bone Neoplasms / therapy*
  • Breast Neoplasms / mortality
  • Breast Neoplasms / pathology
  • Breast Neoplasms / therapy
  • Combined Modality Therapy
  • Diphosphonates / administration & dosage*
  • Female
  • Follow-Up Studies
  • Humans
  • Ibandronic Acid
  • Neoplasm Staging
  • Pain Measurement
  • Pilot Projects
  • Probability
  • Prospective Studies
  • Quality of Life*
  • Radiotherapy Dosage
  • Radiotherapy, Adjuvant
  • Risk Assessment
  • Survival Analysis
  • Time Factors
  • Treatment Outcome

Substances

  • Bone Density Conservation Agents
  • Diphosphonates
  • Ibandronic Acid